deltatrials
Unknown PHASE4 INTERVENTIONAL 1-arm NCT03655847

Acceptable Hemodynamic Changes in Dexmedetomidine for Single Intravenous Bolus Injection

Determination of ED50 and ED95 of Single Bolus Dexmedetomidine in General Anesthesia Patients to Produce Acceptable Hemodynamic Outcomes

Sponsor: Second Affiliated Hospital of Wenzhou Medical University

Conditions Analgesics Delirium Dexmedetomidine Hypnotics and Sedatives Mental Disorders Molecular Mechanisms of Pharmacological Action Neurocognitive Disorders Pathologic Processes Physiological Effects of Drugs Postoperative Complications
Interventions Dexmedetomidine
Updated 7 times since 2018 Last updated: Sep 23, 2019 Started: May 23, 2018 Primary completion: Mar 23, 2020 Completion: Apr 23, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03655847, this PHASE4 trial focuses on Analgesics and Delirium and remains ongoing. Sponsored by Second Affiliated Hospital of Wenzhou Medical University, it has been updated 7 times since 2018, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

~Sep 2018 – ~Mar 2019 · 6 months · monthly snapshotRecruiting~Mar 2019 – ~Oct 2019 · 7 months · monthly snapshotRecruiting~Oct 2019 – ~Jan 2021 · 15 months · monthly snapshotRecruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotRecruiting~Oct 2021 – ~Jul 2024 · 33 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  3. Oct 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

    Status: Recruiting → Unknown Status

  4. Jan 2021 — Oct 2021 [monthly]

    Recruiting PHASE4

  5. Oct 2019 — Jan 2021 [monthly]

    Recruiting PHASE4

▶ Show 2 earlier versions

  1. Mar 2019 — Oct 2019 [monthly]

    Recruiting PHASE4

  2. Sep 2018 — Mar 2019 [monthly]

    Recruiting PHASE4

    First recorded

May 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Second Affiliated Hospital of Wenzhou Medical University
Data source: Second Affiliated Hospital of Wenzhou Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations